Radiothérapie pratique des métastases osseuses symptomatiques

Lagrange, Jean‐Léon; Pan, C.; Calitchi, E.; Diana, C.; Muresan, M.; Wu, Jian; Monkles, Hweej El; Wang, Xiao Wei; Lu, Haije

doi:10.1016/j.rhum.2008.02.005

Cited by 5 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Their treatment requires a multidisciplinary approach. Radiation therapy is one of the key resources available to treat bone metastases near all medical or surgical arsenals [8]. In Africa in general, the diagnosis is not always easy and the management remains poor due to lack of resources both technical and financial, and especially access still limited to appropriate health facilities.…”

Section: Introductionmentioning

confidence: 99%

Profile of Malignant Bone Tumors among Rheumatology Inpatients in Lome (Togo)

Kakpovi¹,

Houzou²,

Fianyo³

et al. 2016

OJRA

View full text Add to dashboard Cite

Background: The reel impact of malignant bone tumors in adults seems unclear in Black Africa. Aim: The aim of this study is to determine the epidemiological and the semiological profile of malignant bone tumors in rheumatology inpatients at Hospital University Center Sylvanus Olympio in Lome. Methods: It was a retrospective study of recorded cases conducted over a period of 19 years in the rheumatology department at Hospital University center Sylvanus Olympio in Lome, Togo. Results: One hundred and sixty-six patients (68 women and 98 men) suffered from a bone tumor. The average age of patients was 55 years old with some extremes cases of 14 and 98 years old. The most affected age group was the one between 46 and 55 years old (40 cases, 24.1%). The disease's average duration was 17 months. These tumors were primary in 43 cases (26%) and secondary in 123 (74%). Metastases were those of prostate (44 cases, 35.7%), breast (12 cases, 9.7%), bronchus (7 cases, 5.7%), cervix (5.7%), and liver (2 cases, 1.6%). Myeloma (34 cases; 79.0%) and osteosarcoma (9 cases; 20.9%) were the main primary malignant bone tumors. However, 41 cases (33.3%) of malignant bone tumors had not been able to label. The spine was the predilection part for all above-mentioned tumors. Conclusion: This study shows the significant part occupied by malignant bone tumors in musculoskeletal diseases within the sub-Saharan population in general and Togo in particular.

show abstract

Section: Introductionmentioning

confidence: 99%

Profile of Malignant Bone Tumors among Rheumatology Inpatients in Lome (Togo)

Kakpovi¹,

Houzou²,

Fianyo³

et al. 2016

OJRA

View full text Add to dashboard Cite

show abstract

“…Their treatment requires a multidisciplinary approach. Radiation therapy is one of the key resources available to treat bone metastases near all medical or surgical arsenals [4]. According to Conroy, the median survival of bone cancer is five months after diagnosis with 5% at five-year survival and 1% at ten-year survival [3].…”

Section: Introductionmentioning

confidence: 99%

Bone Metastases: Experience of Rheumatology Unit of National Hospital University Hubert Koutoukou Maga of Cotonou

Zomalheto¹,

Biaou²,

Yékpè-Ahouansou³

et al. 2015

OJRA

View full text Add to dashboard Cite

Aim: To determine the epidemiological, diagnosis and treatment of secondary bone cancer at the National Hospital University Hubert Koutoukou Maga of Cotonou. Patients and Method: It was a retrospective descriptive cross-sectional study carried out from January 1999 to December 2013 on the records of patients treated in the rheumatology department. The selected files had radiological images of tumor appearance objectified by two radiologists. The diagnosis of secondary bone cancer was confirmed after a bone biopsy or the discovery of a primitive tumor site. Patients with hematologic malignancy and incomplete or insufficiently explored records were excluded. Results: Among 10,292 patients followed in the service, 51 (0.5%) had documented bone metastasis. The sex ratio was 1.83. The mean age of patients was 54 ± 9 [26-85] years, with 53% of those over 60 years old. Secondary cancers were on the spine (74.5%), pelvis (35.3%) and the long bones (39.2%). The primary cancer most frequently found was that of the prostate and breast (45.1% and 27.6%, respectively) followed by genital and digestive cancers (9.8% and 7.8%, respectively). Treatment was dominated by hormone therapy (83%) bisphosphonates (70.5%) and chemotherapy (57%). Conclusion: The profile of bone cancer in Benin hospital is very diverse and dominated by the types and osteolytic ostéocondensant. Primary cancers were dominated by the prostate and breast. Bisphosphonates took an important place in the treatment of the disease.

show abstract